What You Should Know:
- Overture Life today announced a significant $20.6M strategic funding round, bringing its total capital raised to $57M from leading industry investors.
- Supported by Overwater Ventures, GV (formerly Google Ventures), and Khosla Ventures, the $20.6M strategic round reflects deep investor conviction in Overture’s science-led mission.
- The capital will support additional clinical research and product development, accelerating the refinement and
Read More
Hinge Health and Cigna Healthcare Partner to Expand Digital Musculoskeletal Care Access
What You Should Know:
- Hinge Health and Cigna Healthcare today announced a new collaboration designed to broaden access to digital musculoskeletal (MSK) care solutions for more Americans.
- Under this arrangement, Cigna Healthcare's self-insured employer clients now have the option to offer Hinge Health's comprehensive digital MSK platform to their plan members.
Offering a Comprehensive Digital MSK Care Platform
The Hinge Health platform provides an integrated approach
Read More
SimonMed Imaging Partners with Lunit to Deploy AI for Breast Cancer Detection
What You Should Know:
- SimonMed Imaging, one of the largest and most advanced outpatient medical imaging providers in the United States, announced a significant partnership with Lunit, a global leader in AI-driven cancer diagnostics and therapeutics.
- The collaboration aims to bring a new era of artificial intelligence (AI)-powered breast cancer detection to patients across SimonMed's extensive network, marking a major milestone in the company's mission to save lives through
Read More
PGxAI Unveils AI-Driven Genetic Tool to Personalize GLP-1 Treatment
What You Should Know:
- PGxAI, a leader in AI-powered pharmacogenomics released a new report aimed at personalizing treatment regimens for patients taking semaglutide (commonly known by brand names Ozempic and Wegovy) and other widely used weight-management drugs.
- Utilizing advanced artificial intelligence models, the report analyzes patient-specific genetic data to identify and quantify genetic variants that impact drug efficacy and safety, finding that up to a third of
Read More
Womaness and Walmart Partner to Expand Access to Menopause Solutions
What You Should Know:
- Womaness, a modern menopause brand offering a wide range of solutions, has announced a new partnership with Walmart.
- Starting today, Womaness products will be available in select Walmart stores and online, as part of Walmart’s broader Women’s Intimate Health Space initiative. This collaboration aims to address the need for accessible, affordable, and effective menopause products.
Walmart Expands Access to Menopause Solutions
Walmart's customer
Read More
Wondr Health Launches GLP-1 Support For All Benefit Plans
What You Should Know:
- Wondr Health, a leader in digital, evidence-based lifestyle support and behavior-change interventions for weight and obesity management, has announced expansions to its comprehensive metabolic health programs.
- These expansions aim to help employers prevent and manage common and expensive weight-related chronic health conditions, while also mitigating the financial risks associated with GLP-1 coverage.
GLP-1 Support for all Benefit Plans
Wondr
Read More
AMGA and Wilmington Health Launch AMGA Value Care Network
What You Should Know:
- The American Medical Group Association (AMGA) and Wilmington Health have announced an exciting new partnership poised to significantly impact the landscape of value-based care in the United States.
- The two organizations are collaborating to establish the AMGA Value Care Network, a strategic initiative with the ambitious goal of empowering healthcare practices nationwide to successfully implement and thrive within Accountable Care Organization (ACO)
Read More
Eli Lilly’s Oral GLP-1 Shows Positive Trial Results for Type 2 Diabetes
What You Should Know:
- Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes whose blood sugar was inadequately controlled through diet and exercise alone.
- Orforglipron stands out as the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3
Read More
Florida Pediatric Group to Deploy eClinicalWorks and Sunoh.ai Across Enterprise
What You Should Know:
- eClinicalWorks®, an ambulatory cloud EHR provider, today announced that Florida-based Pediatrica Health Group has chosen its intelligent Cloud and AI-driven Electronic Health Record (EHR) system to further improve care coordination and expand access to comprehensive pediatric care across its growing network.
- With a strategic vision for continued exponential growth, Pediatrica’s decision to adopt a robust EHR solution underscores its commitment to thoughtful
Read More
Zoom Launches AI Workplace Platform for Frontline Workers
What You Should Know:
- Zoom Communications has introduced Zoom Workplace for Frontline, a new mobile-first solution designed to enhance communication and workflow management for frontline workers.
- This purpose-built platform aims to equip employees in various sectors, including retail, manufacturing, healthcare, and first response, with tools to improve productivity, performance, and workplace relationships.
Key Features
Zoom Workplace for Frontline offers
Read More
